Dazhe Wang

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

Simon Nadel, Brahm Goldstein, Mark D. Williams et al. · The Lancet · 2007 · 501 citations

Medicine, Pediatrics, Pharmacology +9

Prophylactic Heparin in Patients with Severe Sepsis Treated with Drotrecogin Alfa (Activated)

Marcel Levi, Mitchell M. Levy, Mark D. Williams et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 169 citations

Medicine, Pharmacology, Pharmacotherapy +17

Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years

Christian Confavreux, David K. Li, Mark S. Freedman et al. · Multiple Sclerosis Journal · 2012 · 141 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +16

Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial

Jonathan Barratt, Adrian Liew, See Cheng Yeo et al. · Clinical Journal of the American Society of Nephrology · 2024 · 66 citations · Full text

Medicine, Immunology, Nephrology +17

Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis

Mitchell M. Levy, Marcel Levi, Mark D. Williams et al. · Intensive Care Medicine · 2009 · 12 citations · Full text

Veterinary Medicine, Internal Medicine, Pharmacotherapy +13